Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by VIJAY NAMBI and XIAOMING JIA.
VIJAY NAMBI
Connection Strength
6.040
XIAOMING JIA
  1. Heart Failure and Death in Older Adults With Elevated Cardiac Biomarkers But Without Risk Factors: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2025 Aug 19; 14(16):e042140.
    View in: PubMed
    Score: 0.933
  2. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230.
    View in: PubMed
    Score: 0.788
  3. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450.
    View in: PubMed
    Score: 0.783
  4. Association between circulating Galectin-3 and arterial stiffness in older adults. Vasa. 2021 Nov; 50(6):439-445.
    View in: PubMed
    Score: 0.706
  5. Association between Oral Beta Blocker Therapy and long-term Outcomes after Myocardial Infarction in Individuals with Mildly Reduced or Preserved Left Ventricular Function - a Meta-Analysis of Contemporary Randomized Controlled Trials. Cardiovasc Drugs Ther. 2026 08; 40(4):1447-1455.
    View in: PubMed
    Score: 0.239
  6. High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Chem. 2024 02 07; 70(2):414-424.
    View in: PubMed
    Score: 0.210
  7. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023 11 09; 30(16):1731-1740.
    View in: PubMed
    Score: 0.207
  8. Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure-Reply. JAMA Cardiol. 2023 09 01; 8(9):889-890.
    View in: PubMed
    Score: 0.204
  9. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2022 06; 350:82-89.
    View in: PubMed
    Score: 0.186
  10. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. J Clin Lipidol. 2021 Nov-Dec; 15(6):832-839.
    View in: PubMed
    Score: 0.179
  11. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2021 08; 35(4):793-800.
    View in: PubMed
    Score: 0.174
  12. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.169
  13. Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). Am J Cardiol. 2020 03 15; 125(6):874-879.
    View in: PubMed
    Score: 0.158
  14. Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study". Circulation. 2019 11 12; 140(20):e772-e773.
    View in: PubMed
    Score: 0.157
  15. Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System. Am J Med. 2019 09; 132(9):e693-e700.
    View in: PubMed
    Score: 0.151
  16. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 2019 06 04; 139(23):2642-2653.
    View in: PubMed
    Score: 0.151
  17. Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
    View in: PubMed
    Score: 0.149
  18. Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations. J Clin Lipidol. 2026 Jul 10.
    View in: PubMed
    Score: 0.062
  19. Lipid-lowering therapies to target cardiac allograft vasculopathy after heart transplantation: Current evidence and future directions. J Clin Lipidol. 2026 Feb; 20(2):262-269.
    View in: PubMed
    Score: 0.060
  20. Emerging pharmacological strategies in lipoprotein(a) reduction. Proc (Bayl Univ Med Cent). 2025; 38(5):783-786.
    View in: PubMed
    Score: 0.058
  21. Does Adiponectin Inform Cardiovascular?Risk in Older Adults?: The ARIC Study. JACC Adv. 2025 Mar; 4(3):101625.
    View in: PubMed
    Score: 0.056
  22. Racial/Ethnic Disparities and Determinants of Sufficient Physical Activity Levels. Kans J Med. 2022; 15:267-272.
    View in: PubMed
    Score: 0.047
  23. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. Eur J Prev Cardiol. 2022 03 11; 29(2):e53-e64.
    View in: PubMed
    Score: 0.046
  24. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2021 05 01; 146:15-21.
    View in: PubMed
    Score: 0.043
  25. E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) Survey. Kans J Med. 2020; 13:318-321.
    View in: PubMed
    Score: 0.042
  26. Letter to the Editor: Temporal Trends in E-Cigarette and Cigarette Use Among US Adults by US State: Behavioral Risk Factor Surveillance System, 2016 to 2018. Popul Health Manag. 2021 06; 24(3):414-415.
    View in: PubMed
    Score: 0.042
  27. Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018. Am J Med. 2020 09; 133(9):e508-e511.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.